Page last updated: 2024-10-20

spermine and Non-alcoholic Fatty Liver Disease

spermine has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research Excerpts

ExcerptRelevanceReference
"Insulin resistance is believed to be the key mechanism mediating initial accumulation of fat in the liver, resulting in hepatic steatosis."5.46Kukoamine A attenuates insulin resistance and fatty liver through downregulation of Srebp-1c. ( Chen, Y; Li, G; Wang, N; Zhang, W; Zhou, F, 2017)
"Insulin resistance is believed to be the key mechanism mediating initial accumulation of fat in the liver, resulting in hepatic steatosis."1.46Kukoamine A attenuates insulin resistance and fatty liver through downregulation of Srebp-1c. ( Chen, Y; Li, G; Wang, N; Zhang, W; Zhou, F, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, G1
Zhou, F1
Chen, Y1
Zhang, W1
Wang, N1

Other Studies

1 other study available for spermine and Non-alcoholic Fatty Liver Disease

ArticleYear
Kukoamine A attenuates insulin resistance and fatty liver through downregulation of Srebp-1c.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 89

    Topics: Animals; Dietary Fats; Dose-Response Relationship, Drug; Gene Expression Regulation; Insulin Resista

2017